Augmenix named to Deloitte Technology Fast 500 List

Augmenix, Inc., a company recently acquired by Boston Scientific, received recognition as a Technology Fast 500 company by Deloitte and is ranked #2 in the Medical Devices category. The award recognizes 500 of the fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America based on revenue growth from 2014 to 2017.

In October 2018, Boston Scientific acquired Augmenix, including its innovative SpaceOAR^® Hydrogel System, which helps reduce common and debilitating side effects that men may experience after receiving radiotherapy to treat prostate cancer.

Learn more about the SpaceOAR Hydrogel System.